PureTech Health PLC (NAS:PRTC)
$ 25.9 -2.4901 (-8.77%) Market Cap: 632.07 Mil Enterprise Value: 414.72 Mil PE Ratio: 0 PB Ratio: 1.41 GF Score: 53/100

PureTech Health PLC at Barclays Global Healthcare Conference Transcript

Mar 14, 2023 / 08:05PM GMT
Release Date Price: $28.4
Carter Lewis Gould
Barclays Bank PLC, Research Division - Senior Analyst

Great. Good afternoon, and welcome to Barclays Global Healthcare Conference Day 1. My name is Carter Gould, Senior Biopharma Analyst here at Barclays. It's my pleasure to welcome PureTech to the stage.

Joining us is Bharatt Chowrira, President, CBO, CFO and COO; as well as Eric Elenko, Chief Innovation Officer. Bharatt is going to open up the time here with a brief presentation before we jump into Q&A. Bharatt.

Bharatt M. Chowrira
PureTech Health plc - President, Secretary, Chief Business Finance & Operating Officer and Executive Director

Thanks, Carter, and thanks to the Barclays team for inviting us to present here. For those of you who are not familiar with PureTech, we are based in Boston. We're a biopharmaceutical company. We're fairly unique type of a biopharmaceutical company, and we'll go into a little bit more details as to why we think that way.

We are coming off of a very eventful, successful 2022, where we completed 5 clinical trials. And this year

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot